⌕
Bruker · BRKR · Nasdaq
Tenet — · insufficient data
Compare
$60.62−1.57%At close
$60.62−0.97 (−1.57%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Nov 6, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.

Bruker (BRKR) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Business WireNov 16, 2026 · 07:00 ET
Bruker Announces that Institute Director, Biopharma Entrepreneur and Immunology Leader Dr. Eicke Latz will join its Board of Directors

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors is adding Eicke Latz, MD PhD to serve on its board of directors, effective as of January 1,…

● Zacks Investment ResearchNov 13, 2026 · 12:21 ET
Should You Continue to Retain Bruker Stock in Your Portfolio?

BRKR's diagnostics growth, preclinical imaging expansion and $140 million cost-savings target support its outlook, but uneven academic demand and macroeconomic uncertainty pose risks.…

● Seeking AlphaNov 7, 2026 · 02:46 ET
Bruker: Five Quarters Of Orders Are Still Waiting To Show Up In Revenue

Bruker is positioned for a 2027 operating leverage cycle, with five consecutive quarters of bookings exceeding revenue and significant cost reductions. BRKR's margin expansion is driven by self-help initiatives, not volu…

● Seeking AlphaNov 4, 2026 · 18:44 ETEARNINGS EXPECTED BY FEB 16
Bruker Corporation (BRKR) Q3 2026 Earnings Call Transcript

Bruker Corporation ( BRKR ) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Company Participants Joe Kostka Frank Laukien - Chairman, CEO & President Gerald Herman - Executive VP & CFO Conference Call Participants Pun…

● MarketBeatNov 4, 2026 · 12:15 ETEARNINGS EXPECTED BY FEB 16
Bruker Q3 Earnings Call Highlights

Bruker NASDAQ: BRKR reported third-quarter 2026 revenue growth of 1.6% to $874 million, while non-GAAP earnings per share rose 24.4% year over year to $0.56 as cost-saving actions and favorable product mix supported marg…

● Zacks Investment ResearchNov 4, 2026 · 10:31 ETEARNINGS EXPECTED BY FEB 16
Here's What Key Metrics Tell Us About Bruker (BRKR) Q3 Earnings

Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the…

● Zacks Investment ResearchNov 4, 2026 · 09:56 ETEARNINGS EXPECTED BY FEB 16
Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates

Bruker (BRKR) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.45 per share a year ago.…

● Business WireNov 4, 2026 · 07:00 ETEARNINGS EXPECTED BY FEB 16
Bruker Reports Third Quarter 2026 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2026. Frank H. Laukien, Bruker's President and CEO,…

● Business WireOct 20, 2026 · 16:01 ETEARNINGS EXPECTED BY FEB 16
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2026 financial results before market opening on Wednesday, November 4, 2026. The Company w…

● GuruFocusOct 16, 2026 · 18:53 ET
Is Bruker Corp (BRKR) a Bargain After 3.1% Drop? GF Value Says Undervalued

On October 16, 2026, Bruker Corp (BRKR) shares fell 3.1% to $54.80, reflecting a challenging price performance context with a 52-week range of $32.37 to $66.98.…

● Zacks Investment ResearchOct 8, 2026 · 11:41 ET
Bruker Gains 66.3% in a Year: What's Driving the Rally?

BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.…

● GuruFocusOct 6, 2026 · 18:28 ET
Bruker Corp (BRKR) Shares Fall 5.3% -- GF Value Says Still Overvalued

On October 06, 2026, Bruker Corp (BRKR) shares fell 5.3% to a current price of $60.50, moving within a 52-week range of $32.37 to $66.98. This drop comes amidst…

● Business WireOct 6, 2026 · 07:00 ET
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

BERLIN--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced a seminal bioRxiv preprint, describing a draft atlas of the human plasma proteome at isoform, or proteoform, resolution. The study was …

● Zacks Investment ResearchOct 2, 2026 · 10:51 ET
Why Bruker (BRKR) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

● Defense WorldOct 2, 2026 · 06:41 ET
Bruker (NASDAQ:BRKR) Sets New 1-Year High – Should You Buy?

Bruker Corporation (NASDAQ: BRKR - Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $65.48 and last traded at $65.25, with a volume of 222753 shares traded. …

● Business WireSep 28, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

SINGAPORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-seq…

● MarketBeatSep 26, 2026 · 19:02 ETEARNINGS EXPECTED BY FEB 16
Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound

Bruker NASDAQ: BRKR CFO Gerald Herman said the company's second-quarter results reflected stronger-than-expected organic order bookings and earnings per share, while revenue came in later than anticipated. He attributed …

● Seeking AlphaSep 22, 2026 · 14:29 ET
Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript…

● Business WireSep 21, 2026 · 07:00 ET
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

BERKELEY, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instru…

● Seeking AlphaSep 16, 2026 · 13:51 ET
Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript…

● Seeking AlphaSep 9, 2026 · 11:27 ET
Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript…

● Business WireSep 8, 2026 · 13:21 ET
Bruker Corporation to Present at Upcoming Investor Conferences

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in …

● Business WireSep 4, 2026 · 02:00 ET
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

HANAU, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (Nasdaq: BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) to…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 16. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just BRKR · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.